LANXESS AG (LXS.DE) Stock Fundamental Analysis
FRA:LXS - DE0005470405 - Common Stock
25.54 EUR
+0.5 (+2%)
Overall LXS gets a fundamental rating of 3 out of 10. We evaluated LXS against 70 industry peers in the Chemicals industry. LXS may be in some trouble as it scores bad on both profitability and health. LXS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
LXS had positive earnings in the past year.
In the past year LXS had a positive cash flow from operations.
LXS had positive earnings in 4 of the past 5 years.
LXS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.43%, LXS is doing worse than 61.97% of the companies in the same industry.
LXS has a worse Return On Equity (-3.12%) than 61.97% of its industry peers.
With a Return On Invested Capital value of 0.05%, LXS is not doing good in the industry: 69.01% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.12% | ||
| ROIC | 0.05% |
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LXS has a worse Operating Margin (0.09%) than 67.61% of its industry peers.
In the last couple of years the Operating Margin of LXS has declined.
LXS has a worse Gross Margin (21.07%) than 67.61% of its industry peers.
In the last couple of years the Gross Margin of LXS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.09% | ||
| PM (TTM) | N/A | ||
| GM | 21.07% |
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
2. Health
2.1 Basic Checks
LXS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
LXS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, LXS has more shares outstanding
Compared to 1 year ago, LXS has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.80, we must say that LXS is in the distress zone and has some risk of bankruptcy.
LXS has a Altman-Z score of 1.80. This is in the lower half of the industry: LXS underperforms 61.97% of its industry peers.
LXS has a debt to FCF ratio of 28.05. This is a negative value and a sign of low solvency as LXS would need 28.05 years to pay back of all of its debts.
The Debt to FCF ratio of LXS (28.05) is comparable to the rest of the industry.
LXS has a Debt/Equity ratio of 0.56. This is a neutral value indicating LXS is somewhat dependend on debt financing.
LXS has a Debt to Equity ratio (0.56) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 28.05 | ||
| Altman-Z | 1.8 |
ROIC/WACC0.01
WACC4.82%
2.3 Liquidity
A Current Ratio of 1.90 indicates that LXS should not have too much problems paying its short term obligations.
LXS has a Current ratio of 1.90. This is in the better half of the industry: LXS outperforms 60.56% of its industry peers.
A Quick Ratio of 1.13 indicates that LXS should not have too much problems paying its short term obligations.
LXS's Quick ratio of 1.13 is in line compared to the rest of the industry. LXS outperforms 52.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 244.27% over the past year.
Measured over the past years, LXS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.38% on average per year.
LXS shows a decrease in Revenue. In the last year, the revenue decreased by -5.18%.
LXS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.32% yearly.
EPS 1Y (TTM)244.27%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-1.67%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-12.63%
3.2 Future
Based on estimates for the next years, LXS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.72% on average per year.
LXS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.08% yearly.
EPS Next Y-91.13%
EPS Next 2Y1.79%
EPS Next 3Y9.63%
EPS Next 5Y11.72%
Revenue Next Year-4.84%
Revenue Next 2Y-1.55%
Revenue Next 3Y0.04%
Revenue Next 5Y1.08%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
LXS is valuated correctly with a Price/Earnings ratio of 13.51.
Compared to the rest of the industry, the Price/Earnings ratio of LXS indicates a rather cheap valuation: LXS is cheaper than 83.10% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.24, LXS is valued rather cheaply.
The Price/Forward Earnings ratio is 15.60, which indicates a correct valuation of LXS.
70.42% of the companies in the same industry are more expensive than LXS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.82, LXS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.51 | ||
| Fwd PE | 15.6 |
4.2 Price Multiples
LXS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LXS is cheaper than 70.42% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LXS is valued cheaply inside the industry as 80.28% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.61 | ||
| EV/EBITDA | 7.74 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.79%
EPS Next 3Y9.63%
5. Dividend
5.1 Amount
LXS has a yearly dividend return of 0.40%, which is pretty low.
Compared to an average industry Dividend Yield of 3.15, LXS is paying slightly less dividend.
With a Dividend Yield of 0.40, LXS pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
5.2 History
The dividend of LXS decreases each year by -35.08%.
Dividend Growth(5Y)-35.08%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
The earnings of LXS are negative and hence is the payout ratio. LXS will probably not be able to sustain this dividend level.
DP-6.62%
EPS Next 2Y1.79%
EPS Next 3Y9.63%
FRA:LXS (8/22/2025, 7:00:00 PM)
25.54
+0.5 (+2%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners57.91%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap2.21B
Analysts65.6
Price Target28.09 (9.98%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
Yearly Dividend0.1
Dividend Growth(5Y)-35.08%
DP-6.62%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)265.73%
Min EPS beat(2)179.44%
Max EPS beat(2)352.03%
EPS beat(4)4
Avg EPS beat(4)283.37%
Min EPS beat(4)130.13%
Max EPS beat(4)471.87%
EPS beat(8)7
Avg EPS beat(8)156.69%
EPS beat(12)10
Avg EPS beat(12)114.53%
EPS beat(16)14
Avg EPS beat(16)92.1%
Revenue beat(2)0
Avg Revenue beat(2)-3.33%
Min Revenue beat(2)-4.87%
Max Revenue beat(2)-1.78%
Revenue beat(4)0
Avg Revenue beat(4)-3.41%
Min Revenue beat(4)-4.87%
Max Revenue beat(4)-1.78%
Revenue beat(8)2
Avg Revenue beat(8)-3.63%
Revenue beat(12)3
Avg Revenue beat(12)-2.66%
Revenue beat(16)3
Avg Revenue beat(16)-6.02%
PT rev (1m)-0.93%
PT rev (3m)-5.62%
EPS NQ rev (1m)57.71%
EPS NQ rev (3m)-2976%
EPS NY rev (1m)-91.35%
EPS NY rev (3m)-91.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.56%
Revenue NY rev (1m)-3.49%
Revenue NY rev (3m)-3.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.51 | ||
| Fwd PE | 15.6 | ||
| P/S | 0.35 | ||
| P/FCF | 20.61 | ||
| P/OCF | 5.09 | ||
| P/B | 0.51 | ||
| P/tB | 1.14 | ||
| EV/EBITDA | 7.74 |
EPS(TTM)1.89
EY7.4%
EPS(NY)1.64
Fwd EY6.41%
FCF(TTM)1.24
FCFY4.85%
OCF(TTM)5.01
OCFY19.63%
SpS73.65
BVpS50.47
TBVpS22.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.12% | ||
| ROCE | 0.08% | ||
| ROIC | 0.05% | ||
| ROICexc | 0.06% | ||
| ROICexgc | 0.09% | ||
| OM | 0.09% | ||
| PM (TTM) | N/A | ||
| GM | 21.07% | ||
| FCFM | 1.68% |
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-49.79%
ROICexcg growth 5Y-39.03%
ROICexc growth 3Y-49.29%
ROICexc growth 5Y-40.18%
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score5
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 28.05 | ||
| Debt/EBITDA | 4.27 | ||
| Cap/Depr | 58.11% | ||
| Cap/Sales | 5.13% | ||
| Interest Coverage | 0.14 | ||
| Cash Conversion | 76.37% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 1.8 |
F-Score5
WACC4.82%
ROIC/WACC0.01
Cap/Depr(3y)54.6%
Cap/Depr(5y)69.53%
Cap/Sales(3y)4.97%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)244.27%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-1.67%
EPS Next Y-91.13%
EPS Next 2Y1.79%
EPS Next 3Y9.63%
EPS Next 5Y11.72%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-12.63%
Revenue Next Year-4.84%
Revenue Next 2Y-1.55%
Revenue Next 3Y0.04%
Revenue Next 5Y1.08%
EBIT growth 1Y100.79%
EBIT growth 3Y-48.45%
EBIT growth 5Y-38.23%
EBIT Next Year1226.47%
EBIT Next 3Y155.37%
EBIT Next 5Y78.64%
FCF growth 1Y9.18%
FCF growth 3YN/A
FCF growth 5Y6.85%
OCF growth 1Y-13.57%
OCF growth 3Y7.67%
OCF growth 5Y-4.6%